Get started
Author

Georges Argoud

Observed names: G Argoud, G. M. Argoud, Georges M Argoud, Georges W. Argoud
Observed institution: University of New Mexico
OpenAlex ID: A5113573188
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
2018 · Adrian F Hernandez, Jennifer B Green, et al. · The Lancet · 1,822
PDF
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
2019 · Hiddo J L Heerspink, Hans-Henrik Parving, et al. · The Lancet · 628
PDF
Insulin Suppresses Its Own Secretion In Vivo
1987 · Georges M Argoud, David S Schade, et al. · Diabetes · 112
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
2018 · Erin A Bohula, Benjamin M Scirica, et al. · The Lancet · 93
Underestimation of hepatic glucose production by radioactive and stable tracers
1987 · G. M. Argoud, D. S. Schade, et al. · American Journal of Physiology-Endocrinology and Metabolism · 72
The dipeptidyl peptidase‐4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus
2008 · G. Garcia‐Soria, G. Gonzalez‐Galvez, et al. · Diabetes Obesity and Metabolism · 29
PDF
Absence of the Dawn Glucose Rise in Nondiabetic Men Compared by Age
1989 · M. J. Rosenthal, G. M. Argoud · Journal of Gerontology · 10
C-Peptide suppression test and recurrent insulinoma
1989 · Georges W. Argoud, David S. Schade, et al. · The American Journal of Medicine · 6
The dynamic insulin dose response curve
1986 · G. M. Argoud, David S. Schade · Clinical research
Works count: 9
Citation count: 2,772
H-index: 7
I10-index: 7
Year
Topic
Type